1. Immune-related adverse events of checkpoint inhibitors;Ramos-Casals;Nat. Rev. Dis. Primers.,2020
2. Asthma caused by durvalumab after chemoradiotherapy in two patients with non-small cell lung cancer, Respirol;Uemura;Case Rep.,2021
3. A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: a case report;Hamada;Med. (Baltim.).,2022
4. Nivolumab-induced asthma in a patient with non-small-cell lung cancer;Maeno;Ann. Oncol.,2017
5. Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report;Harada;BMC Pulm. Med.,2021